THERAVIVO

Live / Applied — First extension granted (statement of use) (as of 21 Aug 2025)

What this means for you

Not registered yet, but its 20 Dec 2023 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.

Record

Serial number
98324053
Mark type
Stylized text
Filed
20 Dec 2023
Published for opposition
11 Mar 2025
Attorney of record
William Jackson Matney

Goods and services

  • Class 005 — Pharmaceuticals: Human allograft tissue; Human allograft tissue for wound care; Human allograft tissue for treatment of chronic wounds; Human allograft tissue for treatment of diabetic foot ulcers, venous stasis ulcers, arterial ulcers, pressure ulcers, dehisced surgical wounds, and burns

Owner

Prosecution history

  • 22 Aug 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
  • 21 Aug 2025 — SOU EXTENSION 1 GRANTED
  • 21 Aug 2025 — SOU EXTENSION 1 FILED
  • 21 Aug 2025 — SOU TEAS EXTENSION RECEIVED
  • 06 May 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
  • 11 Mar 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
  • 11 Mar 2025 — PUBLISHED FOR OPPOSITION
  • 05 Mar 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
  • 19 Feb 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
  • 27 Jan 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
  • 27 Jan 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE
  • 27 Jan 2025 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
  • 29 Oct 2024 — APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
  • 29 Oct 2024 — APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
  • 29 Jul 2024 — NOTIFICATION OF NON-FINAL ACTION E-MAILED

View this trademark record on Marksy